Skip to content
sellWeak cluster of 2

Andrew Saik sold $43k of ARVN

Chief Financial Officer at ARVINAS, INC.. 5,700 shares at an average of $7.61, traded Jun 24, 2025, filed Jun 24, 2025.

Warning score
36
Value
$43k
5,700 shares
Holdings after
164,401
-3% from before
From 52-week low
+28%
low $6.07, close $7.74
From 52-week high
-72%
high $28.04, as of Jun 24, 2025

Score components

  • Role
    CFO
    +22
  • Trade size
    $43k at market
    +6
  • Share of holdings sold
    Sold 3.4% of holdings
    0
  • Cluster
    2 insiders selling within 14 days
    +8

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ARVNOct 9, 2026 · close 7.64
Since filing Jun 24, 2025: -1.3%SPY +30.1% · excess -31.3%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001655759-25-000109, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 24, 2025SOpen-market sale
Common Stock
-5,700$7.61$43k164,401Jun 24, 2025

Related signals

Other insiders at ARVINAS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
23Weak
ARVNsell 2
ARVINAS, INC.
Angela M Cacace
Chief Scientific Officer
$19k
2,583 shares
-2%
23Weak
ARVNsell
ARVINAS, INC.
Noah Berkowitz
Chief Medical Officer
$74k
8,658 shares
-7%
58Moderate
ARVNsell 4
ARVINAS, INC.
John G Houston
President and CEO
$524k
31,338 shares
-3%
46Moderate
ARVNsell 4
ARVINAS, INC.
Ian Taylor
President, R&D
$151k
9,020 shares
-5%
38Weak
ARVNsell 4
ARVINAS, INC.
Angela M Cacace
Chief Scientific Officer
$70k
4,207 shares
-4%
30Weak
ARVNsell 4
ARVINAS, INC.
David K Loomis
Chief Accounting Officer
$20k
1,214 shares
-6%
15Weak
ARVNsell
ARVINAS, INC.
David K Loomis
Chief Accounting Officer
$10k
460 shares
-5%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Andrew Saik sold $43k of ARVN | InsiderTell